Skip to main content
OpenTrials
Completed

NCT Number: NCT03967028

Indication of Ceaseran Section in Primigravida According to Robson's Classification

Rate of caesarean section surgery are rising worldwide,but the determinant of this increase,especially in low-income and middle-income countries, are controversial.In 1985,The world Health organization (WHO) stated;(There is no justification for any region to have a ceasearan section rate higher than 10-15%). Despite the lack of scientific evidence indicating any substantial maternal and perinatal benefits from increasing cs rates,and some studies showing that higher rates could be linked to negative consequences in maternal and child health, CS continue to increase world wide

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sex eligibility

Female

Study type

Observational

Primary location

Ahmed Abbas

Assiut, Cairo Governorate, 002, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Nullipara
  • Single fetus .
  • More than 37 weeks .
  • Patients who pass into spontaneous
  • Patient who induced labour

Exclusion criteria

  • Non cephalic presentation.
  • Abnormal lie

Treatment and study plan

cesarean section

Procedure

lower segment cesarean section either elective or emergency

Primary outcomes

  1. The prevalence of etiologies of cesarean section

    Time frame: one month

    determine the rate of cesarean section with different indication according to Robson classification

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
May 30, 2019
Registry last updated
May 9, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.